Tarsus Pharmaceuticals Inc (TARS) earnings · rev $451.4M
These earnings events as JSON? API free 100/dayTarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
This TARS earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported TARS revenue for 2025-12-31 was $451.4M. Net income was -$66.4M. Revenue was up 146.7% from 2024-12-31 to 2025-12-31. TARS currently screens at market cap $2.66B.
When the next TARS 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 146.7% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full TARS research stays on the stock page; the tape stays on the quote page.
TARS earnings FAQ
What are TARS's latest revenue and net income?
Latest cached Tarsus Pharmaceuticals Inc (TARS) revenue for Dec 31, 2025 was $451.4M. Net income was -$66.4M. Statements: https://lician.com/financials/tars
What is TARS's latest diluted EPS?
Latest cached Tarsus Pharmaceuticals Inc (TARS) diluted EPS for Dec 31, 2025 was -$1.59.
What period does the latest TARS earnings print cover?
The latest cached Tarsus Pharmaceuticals Inc (TARS) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did TARS revenue change from the prior cached period?
Cached Tarsus Pharmaceuticals Inc (TARS) revenue was up 146.7% from $183.0M (Dec 31, 2024) to $451.4M (Dec 31, 2025). Statements: https://lician.com/financials/tars
Where are TARS earnings listed?
Cached earnings facts for Tarsus Pharmaceuticals Inc (TARS) are listed at https://lician.com/earnings/tars. Statements: https://lician.com/financials/tars
Not investment advice.